Search research articles
Contact Us
Filters
Showing results (31-40 of 78) with videos related to
Page
of 8
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
August 22, 2024
Gene and Protein Expression of MAGE and Associated Immune Landscape Elements in Non-Small-Cell Lung Carcinoma and Urothelial Carcinomas
Izak Faiena, Sabina Adhikary, Colleen Schweitzer, et al.
BJU International
|
November 4, 2025
Validation of the Testicular Health Outcomes Report (THOR): a testicular cancer health-related quality of life instrument
Samuel A Gold, Amy L Tin, Viranda H Jayalath, et al.
BJU International
|
October 15, 2025
Baseline health-related quality-of-life metrics among patients with testicular germ cell tumours
Samuel A Gold, Rebecca Yu, Viranda H Jayalath, et al.
Leukemia & Lymphoma
|
May 31, 2017
Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma
Matthew J Pianko, Samuel A Funt, David B Page, et al.
Cancer
|
September 16, 2023
Ototoxicity associated with high-dose carboplatin for patients with previously treated germ cell tumors
Samuel A Funt, Andrea Knezevic, Kaamilah Wilson, et al.
European Urology Open Science
|
September 11, 2024
Perioperative Serum MicroRNA 371a-3p and 372-3p Levels in Patients with Clinically Localized Testicular Masses
Richard S Matulewicz, Fady Baky, Andrea Knezevic, et al.
The Annals of Thoracic Surgery
|
September 4, 2020
Thoracic Metastasectomy in Germ Cell Tumor Patients Treated With First-line Versus Salvage Therapy
Raul Caso, Gregory D Jones, Kay See Tan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 29, 2020
Adjuvant Chemotherapy With Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors
Deaglan J McHugh, Samuel A Funt, Deborah Silber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2023
Novel Genetic Subtypes of Urothelial Carcinoma With Differential Outcomes on Immune Checkpoint Blockade
Michal Sarfaty, Mahdi Golkaram, Samuel A Funt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 14, 2025
Erratum: Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease
Jack P Gleeson, Andrea Knezevic, Maria Bromberg, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 78) with videos related to
Sort By:
Page
of 8
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
August 22, 2024
Gene and Protein Expression of MAGE and Associated Immune Landscape Elements in Non-Small-Cell Lung Carcinoma and Urothelial Carcinomas
Izak Faiena, Sabina Adhikary, Colleen Schweitzer, et al.
BJU International
|
November 4, 2025
Validation of the Testicular Health Outcomes Report (THOR): a testicular cancer health-related quality of life instrument
Samuel A Gold, Amy L Tin, Viranda H Jayalath, et al.
BJU International
|
October 15, 2025
Baseline health-related quality-of-life metrics among patients with testicular germ cell tumours
Samuel A Gold, Rebecca Yu, Viranda H Jayalath, et al.
Leukemia & Lymphoma
|
May 31, 2017
Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma
Matthew J Pianko, Samuel A Funt, David B Page, et al.
Cancer
|
September 16, 2023
Ototoxicity associated with high-dose carboplatin for patients with previously treated germ cell tumors
Samuel A Funt, Andrea Knezevic, Kaamilah Wilson, et al.
European Urology Open Science
|
September 11, 2024
Perioperative Serum MicroRNA 371a-3p and 372-3p Levels in Patients with Clinically Localized Testicular Masses
Richard S Matulewicz, Fady Baky, Andrea Knezevic, et al.
The Annals of Thoracic Surgery
|
September 4, 2020
Thoracic Metastasectomy in Germ Cell Tumor Patients Treated With First-line Versus Salvage Therapy
Raul Caso, Gregory D Jones, Kay See Tan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 29, 2020
Adjuvant Chemotherapy With Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors
Deaglan J McHugh, Samuel A Funt, Deborah Silber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2023
Novel Genetic Subtypes of Urothelial Carcinoma With Differential Outcomes on Immune Checkpoint Blockade
Michal Sarfaty, Mahdi Golkaram, Samuel A Funt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 14, 2025
Erratum: Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease
Jack P Gleeson, Andrea Knezevic, Maria Bromberg, et al.
Page
of 8